Literature DB >> 6120389

Low dose oral prednisolone in renal transplantation.

P J Morris, L Chan, M E French, A Ting.   

Abstract

Azathioprine and steroids (prednisone or prednisolone) form the basis of conventional immunosuppression after renal transplantation. Most of the morbidity in the early months after transplantation. Most of the attributed to steroids, which are normally give in high doses. The only justification for giving high doses is a historical one. For this reason a randomised controlled trial was carried out to compare the efficacy of high dose (39 patients) and low dose (33 patients) oral prednisolone, both in combination with azathioprine, in patients given cadaveric renal allografts. Patients were followed up for at least two years after the transplantation. Patient and graft survival were identical in the two groups and the morbidity associated with steroids was impressively lower in patients receiving a low steroid dose. Although the optimal dose of steroids is still unknown, there seems little justification for continued use of high doses of oral steroids with azathioprine after cadaveric renal transplantation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120389     DOI: 10.1016/s0140-6736(82)92042-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation.

Authors:  Michael D Rizzari; Thomas M Suszynski; Kristen J Gillingham; Ty B Dunn; Hassan N Ibrahim; William D Payne; Srinath Chinnakotla; Erik B Finger; David E R Sutherland; Raja Kandaswamy; John S Najarian; Timothy L Pruett; Aleksandra Kukla; Richard Spong; Arthur J Matas
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

Review 2.  Overview of immunosuppression in liver transplantation.

Authors:  Anjana A Pillai; Josh Levitsky
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

3.  Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.

Authors:  T M Suszynski; K J Gillingham; M D Rizzari; T B Dunn; W D Payne; S Chinnakotla; E B Finger; D E R Sutherland; J S Najarian; T L Pruett; A J Matas; R Kandaswamy
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

Review 4.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

5.  The lens after renal transplantation.

Authors:  G A Shun-Shin; P Ratcliffe; A J Bron; N P Brown; J M Sparrow
Journal:  Br J Ophthalmol       Date:  1990-05       Impact factor: 4.638

Review 6.  Primary care of the renal transplant patient.

Authors:  J D Pirsch; R Friedman
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

7.  Steroids and modern immunosuppression.

Authors:  J R Salaman
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

8.  Cytomegalovirus infections in renal transplant recipients.

Authors:  T O Nunan; J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

9.  Early diagnosis and treatment of steroid induced avascular necrosis of bone.

Authors:  J E Nixon
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-10

10.  Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.

Authors:  N R Sinclair
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.